Li Jiajia, Zeng Xiaoting, Yang Fuxun, Wang Lan, Luo Xiaoxiu, Liu Rongan, Zeng Fan, Lu Sen, Huang Xiaobo, Lei Yu, Lan Yunping
Department of ICU, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Front Pharmacol. 2022 Feb 9;13:821358. doi: 10.3389/fphar.2022.821358. eCollection 2022.
Sepsis is a life-threatening organ dysfunction syndrome caused by host response disorders due to infection or infectious factors and is a common complication of patients with clinical trauma, burns, and infection. Resveratrol is a natural polyphenol compound that is a SIRT-1 activator with anti-inflammatory, antiviral, antibacterial, antifungal inhibitory abilities as well as cardiovascular and anti-tumor protective effects. In recent years, some scholars have applied resveratrol in animal models of sepsis and found that it has an organ protective effect and can improve the survival time and reduce the mortality of animals with sepsis. In this study, Medline (Pubmed), embase, and other databases were searched to retrieve literature published in 2021 using the keywords "resveratrol" and "sepsis," and then the potential of resveratrol for the treatment of sepsis was reviewed and prospected to provide some basis for future clinical research.
脓毒症是一种由感染或感染因素引起的宿主反应紊乱导致的危及生命的器官功能障碍综合征,是临床创伤、烧伤和感染患者的常见并发症。白藜芦醇是一种天然多酚化合物,是一种SIRT-1激活剂,具有抗炎、抗病毒、抗菌、抗真菌抑制能力以及心血管和抗肿瘤保护作用。近年来,一些学者将白藜芦醇应用于脓毒症动物模型,发现其具有器官保护作用,可提高脓毒症动物的生存时间并降低死亡率。本研究通过检索Medline(Pubmed)、embase等数据库,使用关键词“白藜芦醇”和“脓毒症”检索2021年发表的文献,进而对白藜芦醇治疗脓毒症的潜力进行综述和展望,为未来的临床研究提供一定依据。